title: Re: Kanai A, et al. mechanisms of action of botulinum neurotoxins, β3-adrenergic receptor agonists, and PDE5 inhibitors in modulating detrusor function in overactive bladders: ICI-RS 2011. Neurourol urodyn 2012;31:300-308.
authors.forename: Masayuki
authors.initials: M
authors.lastname: Takeda
mesh_terms: D058667:Adrenergic beta-3 Receptor Agonists / Q000494:pharmacology*; D000818:Animals; D019274:Botulinum Toxins, Type A / Q000494:pharmacology*; D005260:Female; D058986:Phosphodiesterase 5 Inhibitors / Q000494:pharmacology*; D001743:Urinary Bladder / Q000187:drug effects*; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy*; D053201:Urinary Bladder, Overactive / Q000188:drug therapy*
chemical_list: D058667:Adrenergic beta-3 Receptor Agonists; D058986:Phosphodiesterase 5 Inhibitors; D019274:Botulinum Toxins, Type A